This result exceeds the ‘20/20 rule’ for tumour suppressor gene classification which requires that > 20% of somatic mutations are inactivating [6] and affirms our earlier work demonstrating CTCF’s role as a tumour suppressor [33–35]. The gene discussed is CTCF; the disease is neoplasm.